<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00399633</url>
  </required_header>
  <id_info>
    <org_study_id>Neuropeptide2007</org_study_id>
    <nct_id>NCT00399633</nct_id>
  </id_info>
  <brief_title>Neuropeptides in the Humane Intra- og Extracerebral Circulation.</brief_title>
  <official_title>Neuropeptides in the Humane Intra- og Extracerebral Circulation - in Relation to Sumatriptan in Healthy Volunteers.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Headache Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danish Headache Center</source>
  <brief_summary>
    <textblock>
      The study aim at examining whether Sumatriptan changes the plasma values of the neuropeptides
      vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary
      adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2
      og PGF2α.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is meant to give a better understanding of the basic mechanisms behind migraine,
      and a better understanding of the effects of sumatriptan on the trigemino vascular system.

      The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal
      polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase
      activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood concentration of vasoactive intestinal polypeptide (VIP),</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>calcitonin gene-related protein (CGRP), pituitary adenylate cyclase</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>activating peptide (PACAP,) and the prostanoids</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>6-keto-PGF1α, PGE2, PGD2 and PGF2α, sampled from different</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>venous catheters.</measure>
  </primary_outcome>
  <enrollment type="Actual">16</enrollment>
  <condition>Healthy</condition>
  <condition>Migraine</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sumatriptan</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers

          -  18-50 years,

          -  50-100 kg.

          -  Fertile women must use birth control.

        Exclusion Criteria:

          -  All primary types of headache

          -  Daily intake of medicine except birth control

          -  Pregnancy

          -  Hypertension

          -  Hypotension

          -  other chronic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jakob Møller Hansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danish Headache Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Danish Headache Center</name>
      <address>
        <city>Glostrup, Copenhagen</city>
        <state>Copenhagen</state>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2006</study_first_submitted>
  <study_first_submitted_qc>November 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2006</study_first_posted>
  <last_update_submitted>May 13, 2008</last_update_submitted>
  <last_update_submitted_qc>May 13, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2008</last_update_posted>
  <keyword>VIP</keyword>
  <keyword>PACAP</keyword>
  <keyword>CGRP</keyword>
  <keyword>Prostanoids</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sumatriptan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

